Repligen Co. (NASDAQ:RGEN) Forecasted to Post Q2 2023 Earnings of $0.44 Per Share
Repligen Co. (NASDAQ:RGEN – Free Report) – Equities researchers at SVB Leerink dropped their Q2 2023 EPS estimates for Repligen in a note issued to investors on Friday, July 21st. SVB Leerink analyst P. Souda now expects that the biotechnology company will post earnings per share of $0.44 for the quarter, down from their previous […]